didodecyldimethylammonium has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fathi, M; Nedaei, K; Ramazani, A; Rostamizadeh, K; Shahidi, S | 1 |
1 other study(ies) available for didodecyldimethylammonium and Colonic Neoplasms
Article | Year |
---|---|
Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
Topics: Colonic Neoplasms; Humans; Nanoparticles; Quercetin; RNA, Small Interfering | 2022 |